AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 54 filers reported holding AC IMMUNE SA in Q1 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $447,777 | +160393.5% | 151,532 | +27.3% | 0.00% | – |
Q1 2023 | $279 | +25.7% | 119,027 | +9.4% | 0.00% | – |
Q4 2022 | $222 | -99.9% | 108,806 | +169.0% | 0.00% | – |
Q3 2021 | $271,000 | -55.4% | 40,452 | -47.2% | 0.00% | – |
Q2 2021 | $607,000 | -68.4% | 76,569 | -69.6% | 0.00% | -100.0% |
Q1 2021 | $1,918,000 | +1659.6% | 252,026 | +1092.2% | 0.00% | – |
Q4 2020 | $109,000 | -95.3% | 21,140 | -95.5% | 0.00% | -100.0% |
Q3 2020 | $2,314,000 | -33.5% | 474,129 | -8.3% | 0.00% | -40.0% |
Q2 2020 | $3,481,000 | -4.2% | 517,236 | -1.6% | 0.01% | -37.5% |
Q1 2020 | $3,632,000 | +752.6% | 525,679 | +951.8% | 0.01% | +700.0% |
Q4 2019 | $426,000 | -29.8% | 49,978 | -59.3% | 0.00% | 0.0% |
Q3 2019 | $607,000 | -51.6% | 122,806 | -45.7% | 0.00% | -50.0% |
Q2 2019 | $1,254,000 | +46.3% | 225,974 | +33.1% | 0.00% | +100.0% |
Q1 2019 | $857,000 | -32.7% | 169,759 | +38.1% | 0.00% | -50.0% |
Q1 2017 | $1,273,000 | +33.4% | 122,924 | +67.2% | 0.00% | 0.0% |
Q4 2016 | $954,000 | +11.2% | 73,530 | +41.1% | 0.00% | +100.0% |
Q3 2016 | $858,000 | – | 52,121 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,455,534 | $37,650,000 | 4.22% |
Prosight Management, LP | 710,541 | $3,588,000 | 1.57% |
Opus Point Partners Management, LLC | 39,801 | $201,000 | 0.27% |
PA Capital LLC | 40,055 | $202,000 | 0.21% |
Artal Group S.A. | 1,000,000 | $5,050,000 | 0.21% |
Duquesne Family Office | 1,324,935 | $6,691,000 | 0.19% |
Temasek Holdings (Private) Ltd | 2,614,095 | $13,201,000 | 0.09% |
COHEN LAWRENCE B | 13,350 | $67,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 94,466 | $477,000 | 0.05% |
Tekla Capital Management LLC | 171,813 | $868,000 | 0.04% |